observed MHC downregulation in metastatic LNs compared with its expression in primary lesions in clinical samples of gastric carcinoma
10.1021/jz402762h [4] Wang D, Sun Q, Hokkanen MJ, Zhang C, Lin F-Y, Liu Q, Zhu S-P, Zhou T, Chang Q, He B, Zhou Q, Chen L, Wang Z, Ras RHA and Deng X
The researchers note that about a quarter of those on the lowest dose of these medications gained weight
Factors to discuss include the patient's satisfaction with weight loss achieved, tolerance of side effects, financial considerations including insurance coverage, and personal preferences regarding long-term medication use
66 Avery W
Taylor, MD, FACS General & Robotic Surgeon K